Shujian Wei

709 total citations
28 papers, 493 citations indexed

About

Shujian Wei is a scholar working on Cardiology and Cardiovascular Medicine, Surgery and Pathology and Forensic Medicine. According to data from OpenAlex, Shujian Wei has authored 28 papers receiving a total of 493 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Cardiology and Cardiovascular Medicine, 9 papers in Surgery and 9 papers in Pathology and Forensic Medicine. Recurrent topics in Shujian Wei's work include Cardiac Ischemia and Reperfusion (5 papers), Coronary Interventions and Diagnostics (4 papers) and Cardiac Arrest and Resuscitation (4 papers). Shujian Wei is often cited by papers focused on Cardiac Ischemia and Reperfusion (5 papers), Coronary Interventions and Diagnostics (4 papers) and Cardiac Arrest and Resuscitation (4 papers). Shujian Wei collaborates with scholars based in China, Thailand and Sweden. Shujian Wei's co-authors include Yuguo Chen, Feng Xu, Qiuhuan Yuan, Jiali Wang, Bailu Wang, Chang Pan, Wenqing Ji, Junhui Xing, Yuan Bian and Yu Zhao and has published in prestigious journals such as Circulation, SHILAP Revista de lepidopterología and Biochemical and Biophysical Research Communications.

In The Last Decade

Shujian Wei

27 papers receiving 492 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Shujian Wei China 13 204 136 128 103 79 28 493
Junhui Xing China 16 242 1.2× 84 0.6× 110 0.9× 125 1.2× 89 1.1× 35 571
Fei Fang Canada 11 240 1.2× 112 0.8× 101 0.8× 171 1.7× 67 0.8× 16 649
Nassrene Y. Elmadhun United States 15 182 0.9× 118 0.9× 88 0.7× 138 1.3× 103 1.3× 39 492
Guoxing Li China 15 205 1.0× 124 0.9× 75 0.6× 141 1.4× 82 1.0× 36 629
Shujian Wei China 11 183 0.9× 119 0.9× 85 0.7× 86 0.8× 52 0.7× 22 488
Xianhe Lin China 10 230 1.1× 83 0.6× 228 1.8× 97 0.9× 41 0.5× 15 521
Wanting Shi China 11 263 1.3× 51 0.4× 72 0.6× 120 1.2× 80 1.0× 30 555
Xiaoyang Lai China 13 289 1.4× 73 0.5× 127 1.0× 65 0.6× 69 0.9× 27 551
Yingbin Xiao China 17 293 1.4× 97 0.7× 110 0.9× 203 2.0× 136 1.7× 48 740

Countries citing papers authored by Shujian Wei

Since Specialization
Citations

This map shows the geographic impact of Shujian Wei's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shujian Wei with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shujian Wei more than expected).

Fields of papers citing papers by Shujian Wei

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Shujian Wei. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shujian Wei. The network helps show where Shujian Wei may publish in the future.

Co-authorship network of co-authors of Shujian Wei

This figure shows the co-authorship network connecting the top 25 collaborators of Shujian Wei. A scholar is included among the top collaborators of Shujian Wei based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shujian Wei. Shujian Wei is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Wang, Jiali, Rui Hua, Shuo Wu, et al.. (2024). Carbonylation of Runx2 at K176 by 4-Hydroxynonenal Accelerates Vascular Calcification. Circulation. 149(22). 1752–1769. 17 indexed citations
2.
Zhang, Chuanxin, Xilong Liu, Rui Hua, et al.. (2024). Adenosine kinase protects against acetaminophen-induced acute liver injury by activating autophagy in hepatocytes. Cell Biology and Toxicology. 40(1). 59–59. 1 indexed citations
4.
Wang, Bailu, et al.. (2023). The role of periostin in cardiac fibrosis. Heart Failure Reviews. 29(1). 191–206. 5 indexed citations
5.
Zhang, Chuanxin, et al.. (2022). Mortality in cardiogenic shock patients receiving mechanical circulatory support: a network meta-analysis. BMC Cardiovascular Disorders. 22(1). 48–48. 8 indexed citations
6.
Yu, Han, Chuanxin Zhang, Han Liu, et al.. (2022). Adenosine Kinase Inhibition Prevents Severe Acute Pancreatitis via Suppressing Inflammation and Acinar Cell Necroptosis. Frontiers in Cell and Developmental Biology. 10. 14 indexed citations
7.
Wang, Wenjun, Han Yu, Jiaxin Li, et al.. (2021). 4-Hydroxy-2-Nonenal Promotes Cardiomyocyte Necroptosis via Stabilizing Receptor-Interacting Serine/Threonine-Protein Kinase 1. Frontiers in Cell and Developmental Biology. 9. 721795–721795. 20 indexed citations
9.
Wang, Wenjun, Bailu Wang, Yuguo Chen, & Shujian Wei. (2021). Late Stent Thrombosis After Drug-Coated Balloon Coronary Angioplasty for In-Stent Restenosis. International Heart Journal. 62(1). 171–174. 1 indexed citations
10.
Zhang, Rui, Baoshan Liu, Wenjun Wang, et al.. (2020). Aldehyde Dehydrogenase 2 Protects Against Post-Cardiac Arrest Myocardial Dysfunction Through a Novel Mechanism of Suppressing Mitochondrial Reactive Oxygen Species Production. Frontiers in Pharmacology. 11. 373–373. 33 indexed citations
11.
Wei, Shujian, Bailu Wang, Yu Zhao, et al.. (2019). ALDH2 deficiency inhibits Ox-LDL induced foam cell formation via suppressing CD36 expression. Biochemical and Biophysical Research Communications. 512(1). 41–48. 19 indexed citations
12.
Bian, Yuan, Xin Zhou, Qiuhuan Yuan, et al.. (2019). A small-molecule activator of mitochondrial aldehyde dehydrogenase 2 reduces the severity of cerulein-induced acute pancreatitis. Biochemical and Biophysical Research Communications. 522(2). 518–524. 7 indexed citations
13.
Sun, Yiying, Wenjun Wang, Bailu Wang, et al.. (2019). Poly (ADP‐ribose) polymerase inhibition protects against myocardial ischaemia/reperfusion injury via suppressing mitophagy. Journal of Cellular and Molecular Medicine. 23(10). 6897–6906. 26 indexed citations
14.
Zhao, Yu, Bailu Wang, Jian Zhang, et al.. (2019). ALDH2 (Aldehyde Dehydrogenase 2) Protects Against Hypoxia-Induced Pulmonary Hypertension. Arteriosclerosis Thrombosis and Vascular Biology. 39(11). 2303–2319. 64 indexed citations
15.
Pan, Chang, Yu Zhao, Yuan Bian, et al.. (2018). Aldehyde dehydrogenase 2 Glu504Lys variant predicts a worse prognosis of acute coronary syndrome patients. Journal of Cellular and Molecular Medicine. 22(4). 2518–2522. 7 indexed citations
16.
Liu, Baoshan, Rui Zhang, Shujian Wei, et al.. (2018). ALDH2 protects against alcoholic cardiomyopathy through a mechanism involving the p38 MAPK/CREB pathway and local renin-angiotensin system inhibition in cardiomyocytes. International Journal of Cardiology. 257. 150–159. 18 indexed citations
17.
Ji, Wenqing, Shujian Wei, Junhui Xing, et al.. (2016). Aldehyde Dehydrogenase 2 Has Cardioprotective Effects on Myocardial Ischaemia/Reperfusion Injury via Suppressing Mitophagy. Frontiers in Pharmacology. 7. 101–101. 83 indexed citations
18.
Qin, Weidong, Shujian Wei, Xuping Wang, et al.. (2012). Poly(ADP-ribose) polymerase 1 inhibition protects against low shear stress induced inflammation. Biochimica et Biophysica Acta (BBA) - Molecular Cell Research. 1833(1). 59–68. 23 indexed citations
19.
Li, Xue, Feng Xu, Shujian Wei, et al.. (2011). Acetylation‐dependent regulation of mitochondrial ALDH2 activation by SIRT3 mediates acute ethanol‐induced eNOS activation. FEBS Letters. 586(2). 137–142. 62 indexed citations
20.
Liu, Fuqiang, Xiangli Zhang, Lei Gong, et al.. (2011). Glucagon-like peptide 1 protects microvascular endothelial cells by inactivating the PARP-1/iNOS/NO pathway. Molecular and Cellular Endocrinology. 339(1-2). 25–33. 30 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026